Boston Partners’s Trueblue TBI Stock Holding History
Bought
Maintained
Sold
Other funds holding TBI
RA
IH
ACM
Boston Partners's TBI Position: Q2 2026 in Review
Boston Partners reduced its Trueblue (TBI) stake by 24% in Q2 2026, selling an estimated $4.39M and leaving 2,478,866 shares worth $17.3M. The position accounts for 0.02% of the portfolio, ranked #409.
Boston Partners first reported a position in TBI in Q4 2024 and has held it in 7 quarters since. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.
- Boston Partners held 2,478,866 shares of Trueblue worth $17.3M as of Q2 2026.
- Boston Partners sold 788,526 Trueblue shares in Q2 2026, an estimated $4.39M.
- Trueblue made up 0.02% of Boston Partners's portfolio in Q2 2026, its #409 holding.
- Boston Partners first reported a position in Trueblue in Q4 2024 and has held it in 7 quarters since.
- 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.
Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.